Emerging insights into the role of visceral adipose tissue in diabetic kidney disease
Authors:
Open Access
- 28 November 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1715701
Abstract
Diabetic kidney disease (DKD) is one of the primary microvascular complications of diabetes mellitus and the leading cause of end-stage renal disease. Obesity, which increases the risk of metabolic disorders, plays a crucial role in the onset and progression of DKD. Visceral fat area (VFA), recognized as the gold standard for diagnosing central obesity, can be accurately measured via imaging techniques. Visceral adipose tissue (VAT) regulates disease progression through a variety of potential mechanisms and promotes the occurrence and development of DKD. This review summarizes the assessment methods of VFA, the association between VAT and DKD, and the potential mechanisms by which VAT drives DKD pathogenesis, aiming to provide insights into the role of VAT assessment and its mechanisms in the prevention and treatment of DKD.Keywords
Funding Information
- Science and Technology Fund of Yibin (2022SF007)
This publication has 114 references indexed in Scilit:
- GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis InhibitionAdvanced Science, 2024
- Body Roundness Index and All-Cause Mortality Among US AdultsJAMA Network Open, 2024
- Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte AutophagyAdvanced Science, 2024
- Dock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid MetabolismAdvanced Science, 2023
- MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 DiabetesJournal of Magnetic Resonance Imaging, 2023
- Association between visceral adiposity index and heart failure: A cross‐sectional studyClinical Cardiology, 2023
- Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trialDiabetes/Metabolism Research and Reviews, 2022
- Visceral adiposity index is a better predictor to discriminate metabolic syndrome than other classical adiposity indices among young adultsAmerican Journal of Human Biology, 2022
- The visceral adiposity index and risk of type 2 diabetes mellitus in China: A national cohort analysisDiabetes/Metabolism Research and Reviews, 2021
- Chinese visceral adiposity index: A reliable indicator of visceral fat function associated with risk of type 2 diabetesDiabetes/Metabolism Research and Reviews, 2020